Synaptogenix Increases Stake in Innovative Psilocybin Drug D

Synaptogenix Increases Stake in Innovative Psilocybin Drug Discovery Company through its Partnership with Cannasoul Analytics

Synaptogenix Increases Stake in Innovative Psilocybin Drug Discovery Company through its Partnership with Cannasoul Analytics

lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Israel , Bruce Bernstein , Josh Silverman , Alan Tuchman , Exchange Commission , Israel Institute Of Technology The Technion , Drug Administration , Nasdaq , Prnewswire Synaptogenix Inc , Technion Research Development Foundation , Synaptogenix Inc , Israel Institute Of Technology , Increases Stake , Innovative Psilocybin Drug Discovery Company , Cannasoul Analytics , Technion Research , Development Foundation , Israel Institute , Chief Executive Officer , Synaptogenix Chairman Josh Silverman , Director Bruce Bernstein , Dedi Meiri , Orphan Drug Designation , Psychedelic Drugs Market Analysis ,